Last reviewed · How we verify
NCT05634421
Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysis
trial testing E-learning in Basal Cell Carcinoma in 40 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | Maastricht University Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 December 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- E-learning
Conditions studied
- Basal Cell Carcinoma — all drugs for Basal Cell Carcinoma →
Sponsor
Maastricht University Medical Center
Who can join
18 and older, any sex, with Basal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, various health care professionals will follow an E-learning module in which BCC detection on OCT is explained. Thereafter, the participants will test their skill by assessing OCT-scans. Their performance will be monitored using cumulative-sum analysis. After completion, newly trained OCT assessors will test their diagnostic accuracy for BCC detection on OCT in a exploratory study. The trainability, amount of required training and diagnostic accuracy will be compared between dermatologist and non-dermatologists.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cumulative Sum Analysis-Integrated E-Learning for Differentiation Between Basal Cell Carcinoma and Non-Basal Cell Carcinoma on Optical Coherence Tomography: An Observational Cohort Study.
Wolswijk T, Nelemans PJ, Adan F, van Leersum F, et al · · 2025 · cited 1× · PMID 40579737 · DOI 10.1111/ijd.17918
Verify or expand the search:
- PubMed search for NCT05634421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of E-learning
Trials testing the same drug.
- NCT07080736 — Evaluation of E-learning on Suicide Prevention for Professionals in a Detention Context · NA · recruiting
- NCT06917703 — Effectiveness of a Mobile Health Program in Pregnant Women · NA · enrolling by invitation
- NCT05623475 — Effects of Scenario-based Education Initiative and OSCE for Recognition and Management of Delirium · NA · completed
- NCT04959162 — The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound · NA · completed
- NCT04955132 — Impact of E-learning on Parental Confidence in Managing Food Allergy · NA · unknown
Other recruiting trials for Basal Cell Carcinoma
Currently open trials in the same condition.
- NCT07182240 — Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Ba · NA · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
- NCT06384924 — Raman Spectroscopy and Skin Cancer · recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
Other Maastricht University Medical Center trials
Trials by the same sponsor.
- NCT04603261 — Time to Excretion of Contrast, a Maastricht Prospective Observational Study · withdrawn
- NCT04598516 — Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 · withdrawn
- NCT04597892 — Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast · withdrawn
- NCT07287358 — Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II · NA · not yet recruiting
- NCT07501780 — Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05634421 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maastricht University Medical Center
- Last refreshed: 16 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05634421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing